Regulatory News
Wednesday, June 1, 2016
BRIEF-Allergan receives FDA approval to market Juvéderm Volbella XC
* Received approval from U.S. Food And Drug Administration
(FDA) to market Juvéderm Volbella XC
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment